Alexandre Kreisler

1.7k total citations
45 papers, 869 citations indexed

About

Alexandre Kreisler is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Alexandre Kreisler has authored 45 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 6 papers in Molecular Biology. Recurrent topics in Alexandre Kreisler's work include Parkinson's Disease Mechanisms and Treatments (27 papers), Neurological disorders and treatments (26 papers) and Botulinum Toxin and Related Neurological Disorders (21 papers). Alexandre Kreisler is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (27 papers), Neurological disorders and treatments (26 papers) and Botulinum Toxin and Related Neurological Disorders (21 papers). Alexandre Kreisler collaborates with scholars based in France, Poland and United States. Alexandre Kreisler's co-authors include A. Destée, Luc Defebvre, Régis Bordet, Alain Duhamel, Eugénie Mutez, Pierre Krystkowiak, David Devos, Kathy Dujardin, Michel Lhermitte and Jean‐François Wiart and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Alexandre Kreisler

40 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexandre Kreisler France 16 602 251 201 133 105 45 869
Maria Bozi Greece 14 777 1.3× 334 1.3× 161 0.8× 208 1.6× 133 1.3× 23 957
Vera Tadić Germany 18 556 0.9× 327 1.3× 190 0.9× 76 0.6× 153 1.5× 43 833
Yi‐Min Sun China 18 477 0.8× 225 0.9× 246 1.2× 307 2.3× 127 1.2× 73 919
Wataru Sako Japan 20 915 1.5× 373 1.5× 139 0.7× 122 0.9× 119 1.1× 64 1.2k
Patrizia Tarantino Italy 15 463 0.8× 330 1.3× 229 1.1× 142 1.1× 102 1.0× 29 922
Inés García‐Gorostiaga Spain 15 324 0.5× 143 0.6× 192 1.0× 185 1.4× 114 1.1× 20 692
Xinzhen Yin China 19 394 0.7× 321 1.3× 235 1.2× 168 1.3× 186 1.8× 57 1.0k
Nataša Dragašević Serbia 19 690 1.1× 478 1.9× 229 1.1× 99 0.7× 165 1.6× 47 1.2k
Claudia Caponnetto Italy 17 633 1.1× 167 0.7× 253 1.3× 146 1.1× 224 2.1× 49 999
Andres Deik United States 16 379 0.6× 188 0.7× 140 0.7× 224 1.7× 87 0.8× 33 722

Countries citing papers authored by Alexandre Kreisler

Since Specialization
Citations

This map shows the geographic impact of Alexandre Kreisler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexandre Kreisler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexandre Kreisler more than expected).

Fields of papers citing papers by Alexandre Kreisler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexandre Kreisler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexandre Kreisler. The network helps show where Alexandre Kreisler may publish in the future.

Co-authorship network of co-authors of Alexandre Kreisler

This figure shows the co-authorship network connecting the top 25 collaborators of Alexandre Kreisler. A scholar is included among the top collaborators of Alexandre Kreisler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexandre Kreisler. Alexandre Kreisler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kreisler, Alexandre, et al.. (2024). Doses of Botulinum Toxin in Cervical Dystonia: Does Ultrasound Guidance Change Injection Practices?. Toxins. 16(10). 439–439.
2.
Marquès, Ana, Isabelle Rieu, Bruno Pereira, et al.. (2023). French validation of the Quality of life in Essential Tremor Questionnaire (QUEST) and the Essential Tremor Embarrassment Assessment (ETEA). Revue Neurologique. 179(10). 1128–1133.
3.
Mutez, Eugénie, David Devos, Caroline Moreau, et al.. (2023). Indication for molecular testing by multiplex ligation‐dependent probe amplification in parkinsonism. European Journal of Neurology. 30(6). 1667–1675. 2 indexed citations
4.
Taymans, Jean‐Marc, Eugénie Mutez, S. Bleuse, et al.. (2023). Alterations in the LRRK2-Rab pathway in urinary extracellular vesicles as Parkinson’s disease and pharmacodynamic biomarkers. npj Parkinson s Disease. 9(1). 21–21. 12 indexed citations
5.
Allart, E., et al.. (2021). Late cortical disinhibition in focal hand dystonia. European Journal of Neuroscience. 54(2). 4712–4720. 1 indexed citations
6.
Kreisler, Alexandre, C. Simonin, Adrian Degardin, Eugénie Mutez, & Luc Defebvre. (2020). Anatomy‐guided injections of botulinum neurotoxin in neck muscles: how accurate is needle placement?. European Journal of Neurology. 27(11). 2142–2146. 11 indexed citations
7.
Kreisler, Alexandre, et al.. (2019). Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor. SHILAP Revista de lepidopterología. 9. 7 indexed citations
8.
Leclair‐Visonneau, Laurène, Tiphaine Rouaud, Bérangère Debilly, et al.. (2016). Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsy. Clinical Neurology and Neurosurgery. 146. 35–39. 43 indexed citations
9.
Petyt, G., et al.. (2014). Undetectable specific striatal [123I]-ioflupane binding in patients with parkinsonism. Journal of the Neurological Sciences. 341(1-2). 167–171.
10.
Devos, David, Caroline Moreau, David Maltête, et al.. (2013). Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. Journal of Neurology Neurosurgery & Psychiatry. 85(6). 668–674. 112 indexed citations
11.
Garraux, Gaëtan, Christophe Phillips, Jessica Schrouff, et al.. (2013). Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes. NeuroImage Clinical. 2. 883–893. 65 indexed citations
12.
Carrière, Nicolas, Alexandre Kreisler, Kathy Dujardin, A. Destée, & Luc Defebvre. (2011). Troubles du contrôle des impulsions associés à la maladie de Parkinson : étude d’une cohorte de 35 patients. Revue Neurologique. 168(2). 143–151. 4 indexed citations
13.
Kreisler, Alexandre, Alain Duhamel, Christel Vanbesien-Mailliot, A. Destée, & Régis Bordet. (2010). Differing short-term neuroprotective effects of the fibrates fenofibrate and bezafibrate in MPTP and 6-OHDA experimental models of Parkinson's disease. Behavioural Pharmacology. 21(3). 194–205. 22 indexed citations
14.
Mutez, Eugénie, Frédéric Leprêtre, Vincent Mouroux, et al.. (2010). Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation. Neurobiology of Aging. 32(10). 1839–1848. 78 indexed citations
15.
Tyvaert, Louise, Pierre Krystkowiak, F. Cassim, et al.. (2008). Myoclonus of peripheral origin: Two case reports. Movement Disorders. 24(2). 274–277. 24 indexed citations
16.
Kreisler, Alexandre, Patrick Gelé, Jean‐François Wiart, et al.. (2007). Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: Fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not. Brain Research. 1135(1). 77–84. 72 indexed citations
17.
Kreisler, Alexandre, et al.. (2007). Infarctus cérébraux multiples se présentant comme une dégénérescence cortico-basale : pseudo dégénérescence cortico-basale vasculaire ?. Revue Neurologique. 163(12). 1191–1199. 14 indexed citations
18.
Krystkowiak, Pierre & Alexandre Kreisler. (2007). High doses of botulinum toxinum, from efficacy to safety: Experimental data. Annales de Réadaptation et de Médecine Physique. 50. S12–S16. 1 indexed citations
19.
Tyvaert, Louise, F. Cassim, H. Devanne, et al.. (2006). FC37.4 Modulation of sensorimotor integration in patients with writer’s cramp by subthreshold low-frequency rTMS over the premotor cortex. Clinical Neurophysiology. 117. 1–2. 3 indexed citations
20.
Kreisler, Alexandre, et al.. (1995). Similarity of Folate Receptor Expression in UMSCC 38 Cells to Squamous Cell Carcinoma Differentiation Markers. JNCI Journal of the National Cancer Institute. 87(4). 299–303. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Bozi Breakdown of academic impact, for papers by Vera Tadić Breakdown of academic impact, for papers by Yi‐Min Sun Breakdown of academic impact, for papers by Wataru Sako Breakdown of academic impact, for papers by Patrizia Tarantino Breakdown of academic impact, for papers by Inés García‐Gorostiaga Breakdown of academic impact, for papers by Xinzhen Yin Breakdown of academic impact, for papers by Nataša Dragašević Breakdown of academic impact, for papers by Claudia Caponnetto Breakdown of academic impact, for papers by Andres Deik
Rankless by CCL
2026